Molecular-Clinical Correlation in Pediatric Medulloblastoma: A Cohort Series Study of 52 Cases in Taiwan
Open Access
- 11 March 2020
- Vol. 12 (3), 653
- https://doi.org/10.3390/cancers12030653
Abstract
In 2016, a project was initiated in Taiwan to adopt molecular diagnosis of childhood medulloblastoma (MB). In this study, we aimed to identify a molecular-clinical correlation and somatic mutation for exploring risk-adapted treatment, drug targets, and potential genetic predisposition. In total, 52 frozen tumor tissues of childhood MBs were collected. RNA sequencing (RNA-Seq) and DNA methylation array data were generated. Molecular subgrouping and clinical correlation analysis were performed. An adjusted Heidelberg risk stratification scheme was defined for updated clinical risk stratification. We selected 51 genes for somatic variant calling using RNA-Seq data. Relevant clinical findings were defined. Potential drug targets and genetic predispositions were explored. Four core molecular subgroups (WNT, SHH, Group 3, and Group 4) were identified. Genetic backgrounds of metastasis at diagnosis and extent of tumor resection were observed. The adjusted Heidelberg scheme showed its applicability. Potential drug targets were detected in the pathways of DNA damage response. Among the 10 patients with SHH MBs analyzed using whole exome sequencing studies, five patients exhibited potential genetic predispositions and four patients had relevant germline mutations. The findings of this study provide valuable information for updated risk adapted treatment and personalized care of childhood MBs in our cohort series and in Taiwan.Keywords
Funding Information
- Ministry of Health and Welfare (MOHW107-TDU-B212-114010, MOHW108-TDU-B212-124010)
- Ministry of Science and Technology (MOST 106-2314-B-038-032-MY2, MOST108-2314-B-038-061-MY3)
- Taipei Medical University Hospital (105TMU-TMUH-01-01, 106TMU-TMUH-01-1)
This publication has 83 references indexed in Scilit:
- TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaActa Neuropathologica, 2013
- Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arraysActa Neuropathologica, 2013
- Subgroup-specific structural variation across 1,000 medulloblastoma genomesNature, 2012
- Medulloblastoma exome sequencing uncovers subtype-specific somatic mutationsNature, 2012
- Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasActa Neuropathologica, 2012
- Clonal selection drives genetic divergence of metastatic medulloblastomaNature, 2012
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samplesActa Neuropathologica, 2011
- DNA Polymerases as Potential Therapeutic Targets for Cancers Deficient in the DNA Mismatch Repair Proteins MSH2 or MLH1Cancer Cell, 2010
- The 2007 WHO Classification of Tumours of the Central Nervous SystemActa Neuropathologica, 2007